Showing results (91-100 of 233) with videos related to

Sort By:
Pageof 24
Blood Advances|January 29, 2020
Long-term outcomes after autologous stem cell transplantation for multiple myelomaKatherine K Nishimura, Bart Barlogie, Frits van Rhee, et al.
Blood Advances|July 21, 2026
Efficacy and Safety of BCMA-Targeted Therapies in Relapsed or Refractory AL Amyloidosis: A Descriptive Pooled AnalysisRaghad Alqazaqi, Sean Taasan, William Schwartzman, et al.
American Journal of Hematology|April 21, 2018
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman diseaseSheila K Pierson, Aaron J Stonestrom, Dustin Shilling, et al.
Immunotherapy|February 19, 2016
Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?Sharmilan Thanendrarajan, Faith E Davies, Gareth J Morgan, et al.
Nature Communications|November 26, 2022
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman diseaseSheila K Pierson, Laura Katz, Reece Williams, et al.
Vaccine|January 11, 2014
Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vectorRamesh B Batchu, Oksana V Gruzdyn, Amberly M Moreno-Bost, et al.
The Lancet. Haematology|April 12, 2016
Idiopathic multicentric Castleman's disease: a systematic literature reviewAmy Y Liu, Christopher S Nabel, Brian S Finkelman, et al.
Pageof 24